AKT1 and neurodegenerative disease: By integrating key pathways—including the HSP90 chaperone system, glucocorticoid receptor signaling, AKT, and NF-κB—FKBP51 exerts critical regulatory functions in neurodegenerative diseases, cerebrovascular disorders, and intracranial tumors.